EUR 11.9
(-0.5%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 107.87 Million | 118.43 Million | 210.93 Million | 132.74 Million | 82.31 Million | 82.31 Million |
Net Income | -17.39 Million | 10.19 Million | 53.55 Million | 25.59 Million | 28.89 Million | 28.89 Million |
Depreciation & Amortization | 107.62 Million | 106.9 Million | 90.19 Million | 88.36 Million | 27.56 Million | 25.19 Million |
Deferred income taxes | 6.76 Million | -987 Thousand | -3.82 Million | -1.92 Million | -3.54 Million | -5.06 Million |
Stock-based compensation | - | - | - | 325 Thousand | 2.35 Million | 2.02 Million |
Change in working capital | -5.37 Million | -2.78 Million | 62.08 Million | 19.1 Million | 27.76 Million | 27.76 Million |
Other non-cash items | 27.07 Million | 4.12 Million | 5.1 Million | -319 Thousand | -1.91 Million | 456 Thousand |
Investing Cash Flow | 11.77 Million | -98.81 Million | -40.85 Million | -94.23 Million | -37.73 Million | -37.73 Million |
Investments in PPE | -40.24 Million | -39.17 Million | -32.25 Million | -82.28 Million | -32.14 Million | -32.14 Million |
Acquisitions | -8.51 Million | 364 Thousand | -8.41 Million | -11.95 Million | -5.58 Million | -5.58 Million |
Investment purchases | - | -60 Million | - | - | - | - |
Sales/Maturities of investments | 60.54 Million | 81.52 Million | - | - | - | - |
Other Investing Activities | 1000.00 | -81.52 Million | -181 Thousand | -181 Thousand | 10 Thousand | -2.76 Million |
Financing Cash Flow | -80.7 Million | -94.5 Million | -47.42 Million | -26.28 Million | -21.5 Million | -21.5 Million |
Debt repayment | -136.6 Million | -724 Thousand | -66.12 Million | -6.84 Million | -3.22 Million | -1.5 Million |
Dividends payments | -9.84 Million | -27.13 Million | -53.79 Million | - | -21.4 Million | -20 Million |
Common Stock Repurchased | - | - | -12.33 Million | -6.84 Million | - | - |
Common Stock Issuance | - | - | 3.3 Million | 3.3 Million | - | - |
Other Financing Activities | -2.03 Million | -66.64 Million | 81.52 Million | 5.5 Million | 1.71 Million | -1.5 Million |
Accounts receivables | 20.41 Million | -23.09 Million | 22.32 Million | -14.02 Million | -10 Million | -1.71 Million |
Accounts payables | -47.2 Million | 17.55 Million | 76.7 Million | 26.33 Million | 7.99 Million | 50.96 Million |
Inventory | 9.87 Million | 16.01 Million | -2.26 Million | -7.44 Million | -48.81 Million | -48.81 Million |
Other working capital | -5.4 Million | -13.26 Million | -34.68 Million | 14.24 Million | 78.58 Million | 27.33 Million |
Cash at beginning of period | 66.65 Million | 141.53 Million | 96.71 Million | 84.48 Million | 61.41 Million | 61.41 Million |
Cash at end of period | 105.59 Million | 66.65 Million | 219.36 Million | 96.71 Million | 84.48 Million | 84.48 Million |
Capital Expenditure | -40.24 Million | -39.17 Million | -32.25 Million | -82.28 Million | -32.14 Million | -32.14 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 38.94 Million | -74.88 Million | 122.65 Million | 12.22 Million | 23.07 Million | 23.07 Million |
Free Cash Flow | 67.62 Million | 79.26 Million | 178.67 Million | 50.46 Million | 50.16 Million | 50.16 Million |
Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -16.15 Million | -17.39 Million | 5.82 Million | 6.75 Million | -15.63 Million | 11.75 Million |
Depreciation & Amortization | 27.65 Million | 107.62 Million | 26.46 Million | 27.27 Million | 26.39 Million | 27.72 Million |
Deferred income taxes | - | 6.76 Million | -435 Thousand | 435 Thousand | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -2.65 Million | -5.37 Million | 31.06 Million | 61.89 Million | -32.39 Million | -27.76 Million |
Other non-cash items | 18.28 Million | 27.07 Million | -458 Thousand | 1.67 Million | 38 Thousand | 1.46 Million |
Investing Cash Flow | -14.83 Million | 11.77 Million | -20.72 Million | -7.7 Million | 44.72 Million | -24.79 Million |
Investments in PPE | -10.98 Million | -40.24 Million | -16.06 Million | -7.7 Million | -5.66 Million | -5.26 Million |
Acquisitions | -4.01 Million | -8.51 Million | -4.5 Million | - | - | 464 Thousand |
Investment purchases | - | - | - | - | - | -20 Million |
Sales/Maturities of investments | - | 60.54 Million | - | 10.15 Million | 50.38 Million | 34.37 Million |
Other Investing Activities | 160 Thousand | 1000.00 | -159 Thousand | -10.15 Million | 26.1 Million | -34.37 Million |
Financing Cash Flow | -18.86 Million | -80.7 Million | -17.08 Million | -71.33 Million | -17.57 Million | -17.92 Million |
Debt repayment | - | -136.6 Million | - | - | -17.57 Million | -8000.00 |
Dividends payments | - | -9.84 Million | - | -9.84 Million | -4.92 Million | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 24 Thousand | -2.03 Million | -17.08 Million | -61.48 Million | -17.57 Million | -17.92 Million |
Accounts receivables | - | 20.41 Million | -12.3 Million | -14.98 Million | 17.19 Million | -4.97 Million |
Accounts payables | - | -47.2 Million | 123.78 Million | -86.85 Million | 2.59 Million | 4.97 Million |
Inventory | 67.31 Million | 9.87 Million | -49.61 Million | 58.92 Million | -52.31 Million | 55.01 Million |
Other working capital | - | -5.4 Million | -30.79 Million | 104.81 Million | 123 Thousand | -82.77 Million |
Cash at beginning of period | 104.77 Million | 66.65 Million | 79.69 Million | 56.08 Million | 66.65 Million | 96.19 Million |
Cash at end of period | 105.59 Million | 105.59 Million | 104.77 Million | 74.64 Million | 72.19 Million | 66.65 Million |
Capital Expenditure | -10.98 Million | -40.24 Million | -16.06 Million | -7.7 Million | -5.66 Million | -5.26 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 821 Thousand | 38.94 Million | 25.08 Million | 18.55 Million | 5.54 Million | -29.54 Million |
Free Cash Flow | 23.53 Million | 67.62 Million | 46.83 Million | 89.88 Million | -27.26 Million | 7.91 Million |
CCLDP
MDRM
BRAINP
SELF
NTW
AIMIRT